NCT04162223View on ClinicalTrials.gov

Hepatitis B Vaccine in Seniors

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 29, 2000

Primary Completion Date

May 20, 2003

Study Completion Date

May 20, 2003

Conditions
Hepatitis B Vaccination
Interventions
BIOLOGICAL

Subcutaneous fat injection of Recombivax-HB

Subcutaneous fat injection administration of licensed Hepatitis B Surface Antigen Vaccine (Recombivax-HB) on Days 0, 28, and 180.

BIOLOGICAL

Intramuscular injection of Recombivax-HB

Intramuscular injection administration of licensed Hepatitis B Surface Antigen Vaccine (Recombivax-HB) on Days 0, 28, and 180.

Trial Locations (1)

21201

University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT04162223 - Hepatitis B Vaccine in Seniors | Biotech Hunter | Biotech Hunter